Skip to main content
. 2018 Aug 24;97(34):e11860. doi: 10.1097/MD.0000000000011860

Figure 6.

Figure 6

RR of high-grade neutropenia and thrombocytopenia in patients associated with decitabine versus azacitidine. (A) Forest plot of RR of high-grade neutropenia. (B) Forest plot of RR of high-grade thrombocytopenia (sub-grouped by the type of HMAs). HMAs = hypomethylating agents, RR = relative risks.